Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IBRX
#1042
ImmunityBio, Inc. Common Stock
7.6
0
USD
+4.11%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+4.11%
Mudança mensal
-10.80%
Mudança em 6 meses
+202.79%
Mudança anual
+154.18%
Fechamento anterior
7.3
0
Abrir
7.6
0
Bid
Ask
Mínimo
7.6
0
High
7.6
0
Volume
103
Mercados
Ações
Cuidados de saúde
IBRX
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
109.34 M
397.91 M
435.84 M
673.95 M
853.44 M
1.03 B
—
Valuation ratios
Enterprise value
—
2.24 B
1.96 B
4.15 B
2.37 B
2.31 B
10.68 B
Price to earnings ratio
—
-6.83
-4.59
-4.56
-4.13
-5.21
-22.26
Price to sales ratio
—
2 533.77
7 948.02
4 284.97
121.61
16.08
155.25
Price to cash flow ratio
—
-8.62
-5.65
-7.27
-4.58
-5.97
-24.09
Price to book ratio
—
-9.77
-4.26
-4.54
-3.67
-3.64
-6.31
Enterprise value to EBITDA ratio
—
-7.08
-5.92
-9.5
-6.25
25.23
-301.82
Profitability ratios
Return on assets %
-0.61
-0.74
-1.15
-1.16
-1.08
-0.7
-0.91
Return on equity %
-0.79
1.42
0.93
1
0.85
0.7
0.63
Return on invested capital %
-406.35
-499.19
-255.38
-327.6
-630.3
-482.51
-477.16
Gross margin %
100
100
100
100
100
99.34
397.58
Operating margin %
-82.55 K
-35.36 K
-146.37 K
-58.24 K
-2 334.23
-226
-1 002.3
EBITDA margin %
-74.31 K
-33.84 K
-138.77 K
-55.26 K
-2 215.18
68.17
308.16
Net margin %
-83.23 K
-37.13 K
-173.57 K
-93.76 K
-2 804.77
-310.18
-1 506.74
Liquidity ratios
Quick ratio
—
—
—
—
3.21
5.08
16.76
Current ratio
3.06
0.91
0.28
5.05
3.36
5.1
17.19
Inventory turnover
—
—
—
—
0
0.16
0.15
Asset turnover
0
0
0
0
0.03
0.26
0.27
Solvency ratios
Debt to assets ratio
—
—
-0.04
1.75
0.85
0.73
3.4
Debt to equity ratio
—
—
0.03
-1.5
-0.67
-0.73
-2.6
Long term debt to total assets ratio
—
—
-0.18
1.66
0.74
0.65
2.99
Long term debt to total equity ratio
—
—
0.14
-1.43
-0.58
-0.65
-2.29
Per share metrics
Operating cash flow per share
—
-0.71
-0.84
-0.72
-0.56
-0.33
-0.34
EBIT per share
—
-0.85
-0.88
-0.71
-0.49
-0.28
-0.28
EBITDA per share
—
-0.81
-0.83
-0.68
-0.47
0.08
0.1
Total debt per share
—
—
-0.03
1.73
0.47
0.4
1.56
Cash per share
—
0.81
0.27
0.52
0.21
0.26
0.78
Net current asset value per share
—
0.86
0.35
0.58
0.26
0.34
1.05
Tangible book value per share
—
-0.63
-1.17
-1.19
-0.72
-0.56
-2.5
Working capital per share
—
-0.09
-0.9
0.46
0.19
0.28
0.81
Book value per share
—
-0.62
-1.12
-1.15
-0.7
-0.54
-2.43
Notícias
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
Why Is ImmunityBio Stock Rallying Thursday? - ImmunityBio (NASDAQ:IBRX)
ImmunityBio registra receita de US$ 44,2 milhões no 1º tri, alta de 168% na comparação anual
ImmunityBio responde a preocupações da FDA sobre conformidade promocional
ImmunityBio: No Need To Rush Into Buying Today - Why I'm Downgrading To Hold (NASDAQ:IBRX)
Ações da ImmunityBio disparam com acordo de financiamento de US$ 100 milhões
ImmunityBio garante financiamento de US$ 75 milhões e converte US$ 25 milhões de dívida em ações
ImmunityBio vs. Moderna: Which Biotech Has More Upside Potential?
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)
Estudo de câncer de bexiga da ImmunityBio considerado adequadamente dimensionado
Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims